Aridis Pharmaceuticals, Inc. Skyrocketed
Fri, Sep 22, 2023 at 07:29 PM
Aridis Pharmaceuticals, Inc. (ARDS:NASDAQ) soared at $0.11, representing a gain of 22.2%. On Fri, Sep 22, 2023, ARDS:NASDAQ touched a New 2-Week High of $0.11. From Fri, Sep 08, 2023, the stock recorded 50.00% Up Days and 27.27% Green Days
The stock spiked on Wed, Jul 12, 2023 at $0.41 with a volume of 23M+.
About Aridis Pharmaceuticals, Inc. (ARDS:NASDAQ)
Aridis Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is engaged in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections.
Top 10 Gainers:
- Digital Transformation Opportunities Corp. (DTOC:NASDAQ), 89.56%
- Lifezone Metals Limited (LZM:NYSE), 37.5%
- Cheche Group Inc. (CCG:NASDAQ), 31.45%
- Bellicum Pharmaceuticals, Inc. (BLCM:NASDAQ), 29.01%
- Ohmyhome Limited (OMH:NASDAQ), 28.86%
- Mondee Holdings Inc. (MOND:NASDAQ), 25.86%
- Aridis Pharmaceuticals, Inc. (ARDS:NASDAQ), 22.15%
- Yunhong CTI Ltd. (CTIB:NASDAQ), 21.83%
- Etao International Co. Ltd. (ETAO:NASDAQ), 20.34%
- Warrantee Inc. (WRNT:NASDAQ), 19.96%